Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (8-9), 1311-1315
- https://doi.org/10.1016/0959-8049(92)90506-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987
- Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresisCancer Chemotherapy and Pharmacology, 1986
- Phase-I?II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomasCancer Chemotherapy and Pharmacology, 1985
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1982
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- Pharmacology of intravenous melphalan in patients with multiple myelomaCancer Treatment Reviews, 1979
- Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant diseaseEuropean Journal of Cancer (1965), 1978
- High-Pressure Liquid Chromatographic Analysis of Melphalan in PlasmaJournal of Pharmaceutical Sciences, 1978